Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCL2-associated athanogene pseudogene (ENSG00000262708) is a non-coding genetic element related by sequence to the BCL2-associated athanogene (BAG) gene family, which encodes co-chaperone proteins that modulate apoptosis and stress response via interactions with BCL-2 and HSP70/HSC70 proteins[1][2][4]. Unlike its functional counterparts (BAG1–BAG6), the pseudogene does not produce a functional protein and currently has no known biological, diagnostic, or therapeutic relevance[4]. It is sometimes confused with the active genes in the BAG family, which are involved in regulating cell death, cancer progression, and neurodegeneration, but pseudogenes like ENSG00000262708 are not considered drug targets or receptors[4]. If you intended to inquire about one of the *functional* BCL2-associated athanogene genes (for example, BAG1, BAG2, etc.), please specify, as these proteins have substantial and well-characterized roles in human biology and disease, especially in apoptosis and cancer[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2-associated athanogene pseudogene.